Weekly Communique #33
26 November, 2020
WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are below. Taskforce reviewing changes to WHO guidance on remdesivir for adults Last week, the World Health Organisation (WHO) modified its recommendation on remdesivir to a conditional recommendation against its use for all hospitalised patients regardless of disease...